Beta Bionics (BBNX) Receivables (2023 - 2026)

Beta Bionics has disclosed Receivables across 4 years of filings, most recently posting $15.9 million for Q1 2026.

• Receivables for Q1 2026 came in at $15.9 million, up 75.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.9 million (up 75.56% YoY), and the FY2025 annual result was $17.3 million, up 44.0% from the prior year.
• Receivables came in at $15.9 million for Q1 2026 at Beta Bionics, down from $17.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $17.3 million in Q4 2025 to a low of $4.4 million in Q4 2023.
• The 4-year median for Receivables is $11.7 million (2025), against an average of $11.7 million.
• Across the five-year window, Receivables surged 169.69% in 2024 and jumped 44.0% in 2025, its largest moves.
• Beta Bionics' Receivables stood at $4.4 million in 2023, then soared by 169.69% to $12.0 million in 2024, then surged by 44.0% to $17.3 million in 2025, then fell by 7.92% to $15.9 million in 2026.
• The last three Receivables figures came in at $15.9 million (Q1 2026), $17.3 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.